(Q36609858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Nikolas K. Haass

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Katherine L Nathanson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

R Contractor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

J T Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

C A Medina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

K T Flaherty

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M Herlyn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

23 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

445-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

24 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Distinct sets of genetic alterations in melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

B-RAF is a therapeutic target in melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Amplification of CDK4 and MDM2 in malignant melanoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360037

Suppression of BRAF(V599E) in human melanoma abrogates transformation

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17245336

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6603596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

release_t5z2mshfwfeljg6hjcxg5mwe24

24 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t5z2mshfwfeljg6hjcxg5mwe24

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17245336%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

17245336

1 reference